English
This article is from The Indian Journal of Medical Research , volume 135 . Abstract Background & objectives:: Breast cancer is the second most common malignancy in Indian women. Among the members of the steroid receptor superfamily the role of estrogen and progesterone receptors (ER and PR) is well established in breast cancer in predicting the prognosis and management of therapy, however, little is known about the clinical significance of androgen receptor (AR) in breast carcinogenesis. The present study was aimed to evaluate the expression of AR in breast cancer and to elucidate its clinical significance by correlating it with clinicopathological parameters, other steroid receptors (ER and PR) and growth factors receptors (EGFR and CD105). Methods:: Expression of AR, ER, PR, epidermal growth factor receptor (EGFR) and endoglin (CD105) was studied in 100 cases of breast cancer by immunohistochemistry (IHC). Risk ratio (RR) along with 95% confidence interval (CI) was estimated to assess the strength of association between the markers and clinicopathological characteristics. Categorical principal component analysis (CATPCA) was applied to obtain new sets of linearly combined express
Sign in with your free account to read, download EPUBs or listen.
Ebook · Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors. · Mishra, Ashwani K., Agrawal, Usha, Negi, Shivani, Bansal, Anju, Mohil, R., Chintamani, Chintamani, Bhatnagar, Amar, Bhatnagar, Dinesh · Internet Archive